Identifying Minor Histocompatibility Antigens Using High-Throughput Screening
Author Information
Author(s): Hombrink Pleun, Hadrup Sine R., Bakker Arne, Kester Michel G. D., Falkenburg J. H. Frederik, von dem Borne Peter A., Schumacher Ton N. M., Heemskerk Mirjam H. M.
Primary Institution: Leiden University Medical Center
Hypothesis
Can genome-wide prediction of minor histocompatibility antigens (MiHA) be effectively coupled with T-cell isolation?
Conclusion
The study demonstrates the technical feasibility of high-throughput analysis of antigen-specific T-cell responses, but highlights limitations in the biological relevance of detected T-cell responses.
Supporting Evidence
- 973 polymorphic peptides were predicted and screened for HLA-A2 binding.
- 71 peptide-reactive T-cell populations were generated.
- Two high-affinity T-cell populations were identified, but only one recognized endogenously processed antigen.
Takeaway
Researchers are trying to find new ways to identify specific proteins that can help the immune system fight cancer, but they found that many of the immune responses they detected might not actually work in real patients.
Methodology
The study used genome-wide prediction of MiHA coupled with T-cell isolation through pMHC-tetramer-based enrichment and flow cytometry.
Potential Biases
Potential clonal deletion of high-avidity T-cells due to self-antigen presentation.
Limitations
Many isolated T-cell populations were of low or intermediate avidity and did not recognize endogenously processed antigens.
Participant Demographics
Patients with hematological malignancies undergoing allogeneic stem cell transplantation.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website